Refine
Year of publication
Document Type
- Article (454)
- Conference Proceeding (23)
- Part of a Book (18)
- Patent (17)
- Book (9)
- Preprint (1)
Language
- English (522) (remove)
Has Fulltext
- no (522) (remove)
Keywords
- Heparin (3)
- Chemometrics (2)
- IR spectroscopy (2)
- NMR spectroscopy (2)
- Principal component analysis (2)
- Standardization (2)
- (R)- or (S)- gamma-valerolactone (1)
- 4-hydroxy valeric acid (1)
- Alginate beads (1)
- Analytics (1)
- Authenticity (1)
- Bioeconomy (1)
- Bioethanol (1)
- Biomass (1)
- Biorefinery (1)
- Biorefinery definitions (1)
- Bladder (1)
- Bragg peak (1)
- CRISPR/Cas9 (1)
- Chimeric liver-humanized mice (1)
- Chiralidon-R (1)
- Chiralidon-S (1)
- Crude heparin (1)
- Cyclotron production (1)
- Decentral (1)
- Dehydrogenase (1)
- Detergent protease (1)
- Deuterated solvents (1)
- Deuterium NMR (1)
- Diaphorase (1)
- Drug distribution (1)
- Drug metabolism (1)
- Enzymatic biosensor (1)
- Extracellular enzymes (1)
- Ga-68 (1)
- Growth modelling (1)
- Hypersecretion (1)
- IR (1)
- Inorganic ions (1)
- Introduction (1)
- Ions (1)
- Knockout mice (1)
- Levulinic acid (1)
- Lignocellulose feedstook (1)
- Linear discriminant analysis (1)
- Manufacturer (1)
- Marker-free mutagenesis (1)
- Mechanical (1)
- Mechanical simulation (1)
- Medical radionuclide production (1)
- Metal contaminants (1)
- Microfluidic solvent extraction (1)
- Minor chemistry (1)
- Molecular modelling (1)
- Molecular weight determination (1)
- NMR (1)
- On-site (1)
- P2G (1)
- PLS-regression (1)
- Physical chemistry (1)
- Physical chemistry basics (1)
- Physical chemistry starters (1)
- Pre-treatment (1)
- Process schemes (1)
- Quality control (1)
- Quantum chemistry (1)
- Reconstruction (1)
- Renewable resources (1)
- Simultaneous determination (1)
- Soft independent modeling of class analogy (1)
- Stenotrophomonas maltophilia (1)
- Thermodynamics as minor (1)
- Toxicology (1)
- USP (1)
- Uracil-phosphoribosyltransferase (1)
- Ureter (1)
- actuator-sensor system (1)
- aspergillus (1)
- bacterial cellulose (1)
- bi-enzyme biosensor (1)
- bioavailability (1)
- biodegradable polymers (1)
- biological dosimeter (1)
- biomethane (1)
- borehole disposal (1)
- bubble column (1)
- capacitive field-effect sensor (1)
- coculture (1)
- deficit irrigation (1)
- disposal facility (1)
- drug metabolising enzymes (1)
- drug–drug interactions (1)
- elastomers (1)
- enzyme kinetics (1)
- enzyme-logic gate (1)
- exopolysaccharides (1)
- filamentous fungi (1)
- genome engineering (1)
- geological disposal (1)
- glycine (1)
- human metabolites (1)
- hydrogel (1)
- hydrogels (1)
- light-addressable electrode (1)
- light-addressable potentiometric sensor (1)
- mechanical properties (1)
- methanation (1)
- microfluidics (1)
- micronutrients (1)
- neutrons (1)
- nuclear waste (1)
- onion (1)
- optical fibers (1)
- penicillinase (1)
- plug flow reactor (1)
- polyaspartic acid (1)
- prebiotic (1)
- proton therapy (1)
- protons (1)
- pullulan (1)
- qNMR (1)
- relative dosimetry (1)
- retention time (1)
- rubber (1)
- superabsorbent polymers (1)
- supramolecular structures (1)
- swelling properties (1)
- theory and modeling (1)
- tobacco mosaic virus (TMV) (1)
- transporters (1)
- urease (1)
- water economy (1)
- yield (1)
Institute
- Fachbereich Chemie und Biotechnologie (522) (remove)
In humans, 75% of all drugs are metabolized by the cytochrome P450-dependent monooxygenase system. Enzymes encoded by the CYP2C, CYP2D, and CYP3A gene clusters account for ∼80% of this activity. There are profound species differences in the multiplicity of cytochrome P450 enzymes, and the use of mouse models to predict pathways of drug metabolism is further complicated by overlapping substrate specificity between enzymes from different gene families. To establish the role of the hepatic and extrahepatic P450 system in drug and foreign chemical disposition, drug efficacy, and toxicity, we created a unique mouse model in which 30 cytochrome P450 genes from the Cyp2c, Cyp2d, and Cyp3a gene clusters have been deleted. Remarkably, despite a wide range of putative important endogenous functions, Cyp2c/2d/3a KO mice were viable and fertile, demonstrating that these genes have evolved primarily as detoxification enzymes. Although there was no overt phenotype, detailed examination showed Cyp2c/2d/3a KO mice had a smaller body size (15%) and larger livers (20%). Changes in hepatic morphology and a decreased blood glucose (30%) were also noted. A five-drug cocktail of cytochrome P450 isozyme probe substrates were used to evaluate changes in drug pharmacokinetics; marked changes were observed in either the pharmacokinetics or metabolites formed from Cyp2c, Cyp2d, and Cyp3a substrates, whereas the metabolism of the Cyp1a substrate caffeine was unchanged. Thus, Cyp2c/2d/3a KO mice provide a powerful model to study the in vivo role of the P450 system in drug metabolism and efficacy, as well as in chemical toxicity.